Introduction
Large cystic metastatic brain tumors can be treated with surgical resection, radiation therapy and stereotactic radiosurgery. However, single treatment modality is not effective to improve the quality of life for patients harboring these tumors. In most cases, cystic tumor can not be resected totally due to its eloquent location or patient's physical condition after chemotherapy. Radiotherapy alone is not possible due to large volume with mass effect and its effectiveness is not evaluated. Stereotactic radiosurgery alone is also dangerous due to its large volume. Therefore, in the management of large cystic metastatic brain tumors, multimodality treatment, cyst aspiration and radiosurgery with the same stereotactic frame is one option.
Treatment and outcome

Mechanism of cyst formation
Cystic metastatic brain tumors are common from lung cancer, and non small cell lung cancer is the most common pathology. Sometimes, even in the same pathology, multiple metastatic tumors have cystic and/or solid component. The cause of cyst formation was not clearly established. Stem et al. suggested that the relatively large amounts of protein in cystic fluid resembled that present in inflammatory exudates, which could be the result of increased permeability of pathologic vessels and mesodermal reactive processes. Cumings et al. also suggested that formation of cystic fluid could be explained by tumor degeneration followed by transudation of fluid from blood vessels. Alternatively, Gardner et al. suggested that fluid accumulating in brain tumors is merely interstitial fluid without its normal drainage route because of the absence of lymphatics in the surrounding brain.
Surgical treatment
Conventionally, the presence of a large cystic brain tumor has been regarded as an indication for surgery. Yoshida and Morii advocated surgical treatment for patients with large cystic lesions, providing rapid relief of neurological symptoms caused by mass effect. However, if the lesions are located deep in the brain or adjacent to eloquent area, surgical www.intechopen.com procedures may result in severe neurologic deficits. In addition, surgical procedures are not possible nor effective for patients in poor general condition or those with multiple lesions.
Stereotactic radiosurgery
From the past decade, stereotactic radiosurgery, particularly with Gamma Knife, have gained increasing relevance in the treatment of cerebral metastatic tumors. The increasing use of this technique is attributable to minimal invasiveness, a substantial reduction in hospitalization time and cost with an excellent local tumor control rates even in radioresistant tumor types and a very low associated morbidity. Moreover, although there had been no direct randomized clinical comparisons of Gamma Knife Radiosurgery with other surgical-radiation protocols, the results of Gamma Knife Radiosurgery in patients with solitary lesions were similar or superior to those obtained using other methods. If the tumors are located in the eloquent areas or in the deep locations, or have large cystic component, it is difficult to remove the tumor completely. Also, large cystic brain metastases do not appear suitable for radiosurgery, because the volume of the lesion is the limiting factor for radiosurgery given that it correlates with radiation induced complication. Pan et al. reported that tumors with large cystic components (> 10 cc) were not effectively controlled by Gamma Knife Radiosurgery alone.
Cyst aspiration and stereotactic radiosurgery
In large cystic tumors, Gamma Knife Radiosurgery after stereotactic cyst aspiration could be the better treatment modality than surgical resection or Gamma Knife Radiosurgery alone. Stereotactic cyst aspiration is a safe and effective procedure. Stereotactic cyst aspiration reduced tumor volume in most of our cases and relieved the neurologic symptom rapidly. The mean volume reduction after aspiration was about 76% compared to the preradiosurgical tumor volume in our results and we could increase the prescription dose to the tumor margin. The high viscosity of cystic contents can make aspiration difficult. But even in the case of intratumoral hemorrhage which was noted in MR images before radiosurgery, aspiration was not difficult because hemorrhage was mixed with cystic fluid. Collapsed cystic tumor after aspiration became smaller than initial tumor volume, but remained as a irregular shape. These irregular shaped mass made dose planning difficult in the radiosurgical procedure and needed multiple small isocenters. This treatment method is composed of two stereotactic procedures with a single frame application. Stereotactic cyst aspiration and Gamma Knife Radiosurgery are performed with a single frame application on the same day with pre and post operative MR guidance. When large cystic tumors were multiple or even septated, aspiration is relatively easy and not difficult to perform under MR guidance. As we experienced several cases of cystic fluid reaccumation in the follow-up period after radiosurgery, Ommaya reservoir was applied after cyst aspiration. Combined methods, aspiration and radiosurgery were performed in the same day if patient's condition was permitted. But in some cases, the two procedure time was too long, when the patient had have multiple brain metastases or patient's condition was unable to have frame fixation for several hours. In that case, we performed stereotactic cyst aspiration and Ommaya insertion first and delayed Gamma Knife Radiosurgery several days later. The time period of www.intechopen.com Ommaya insertion and Gamma Knife Radiosurgery was usually within 7 days, because some cases had have rapid tumor progression or reaccumulation of the cystic fluid. Applying Ommaya reservoir can make repeated aspiration without difficulty during and after radiosurgery.
Treatment result
The result of cyst aspiration combined with radiosurgey was rarely reported in the literature. Franzin et al. reported that preoperative tumor volume (mean volume 21.8 cc) was decreased about 46% postoperatively(mean volume 10.1 cc) and he could irradiate above 18 Gy to the tumor margin. He also reported that 92.3% of tumor control rates, overall median survival time was 15 months, the acturarial survival rates at 1 and 2 years was 54.7% and 34.2%, respectively and 26.3% of patients died from neurological progression. In our study, preoperative tumor volume( mean 24.2cc) decreased about 76% postoperatively( mean 5.6cc ), irradiated 20 Gy to the tumor margin. Our results showed that the tumor control rates were 50%, the overall median survival was 17.6 months and 11.1% of the patient died from progression of the brain metastases after treatment ( Table 1 , 2), ( Fig 1, 2) . Tendulkar et al. reported that median survival was reported to be 8.7 months after subtotal resection for single brain metastasis and 10.6 months after gross total resection of a single brain metastasis. Although it is difficult to directly compare these findings, the results of Gamma Knife Radiosurgery after stereotactic cyst aspiration of large cystic metastases were as good as that of gross total surgical resection of single brain metastasis. The results of combined treatment modality, median survival and tumor control rates are nearly the same as the results of radiosurgery for solid metastatic brain tumors as reported in Coffey, Flickinger et al., Lutterbach et al. and Sansur et al. www.intechopen.com Patient's prognosis is related to numerous parameters, such as KPS score, RPA class, age, location, number of cerebral lesions, character of primary tumor. Among them, RPA class is known as the most important prognostic factor. Tendulkar et al. reported that patients with unresectable brain metastases classified into RPA class I, II, and III, the median survival time was 7.1 months, 4.2 months and 2.3 months respectively. Lutterbach et al. reported median survival time as 13.4, 9.3 and 1.5 months in RPA class I, II and III, respectively. We observed median survival of 17.8 months, 10.9 months, and 6.1 months in RPA classes I, II and III, respectively. These data and our results confirmed that RPA class is an important tool to predict the patient prognosis in metastatic brain tumors. Moreover, some patients in RPA class III were too weak to permit general anesthesia. But, this combined treatment modality does not require general anesthesia. These findings further reinforce the efficacy of Gamma Knife Radiosurgery after stereotactic cyst aspiration for unresectable cystic brain metastases. Perfoming Ommaya insertion and cyst aspiration just before Gamma Knife Radiosurgery is the most recommended procedure when the metastatic tumors have a large cyst even patient 's condition is not good after chemotherapy or poor general condition.
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Complications
Ommaya reservoir insertion carries risks such as infection, leptomeningeal dissemination or tumor recurrence along the tube site. We have one case of this complication, tumor recurrence along the tube site, but there was no procedure related mortality nor morbidity. Another possible complications include hemorrhage, neurosurgical deficits and seizures. The mortality rate in several large series has been less than 1%, and complication rates vary from 0% to 7%. The complications of stereotactic radiosurgery are related to the effects of radiation on the brain and structures in proximity to the lesions. Significant early complications include www.intechopen.com seizures and worsening neurological deficits, but they are very rare. Approximately onethird of patients experiences mild transient symptoms, including headache, nausea and dizziness. Late complications occur 6 to 9 months after the procedure and can include neurologic symptoms according to the tumor location. Patients may become symptomatic from radiation necrosis or local brain edema in the follow-up periods. Franzin et al. reported that there was no acute complication and 7.6% of the patients experienced radionecrosis after stereotactic aspiration and Gamma Knife Radiosurgery of cystic brain metastases.
Conclusion
Cyst aspiration and stereotactic radiosurgery with a same stereotactic frame reduced tumor volume, relieving acute symptoms, permitting decrease in radiation dose to the brain, increasing tumor control rates, increasing median survival, decreasing the associated risks of radiation necrosis and post-radiation complications. Our results support the usefulness and safety of stereotactic radiosurgery after cyst aspiration for large cystic metastatic brain tumors.
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